Carbapenems (ASM)

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.

April 16, 2021

The Effects of Antimicrobial Resistance and the Compatibility of Initial Antibiotic Treatment on Clinical Outcomes in Patients With Diabetic Foot Infection.

The International Journal of Lower Extremity Wounds
Nese SaltogluKLİMİK Society, Diabetic Foot Study Group
April 16, 2021

Emergence of carbapenem resistant Acinetobacter baumannii clonal complexes CC2 and CC10 among fecal carriages in an educational hospital.

International Journal of Environmental Health Research
Mohsen NazariFarzad Badmasti
April 16, 2021
Case Report
Open Access

Case Report: Metagenomic Next-Generation Sequencing in Diagnosis of Talaromycosis of an Immunocompetent Patient.

Frontiers in Medicine
Jiejun ShiGuoqing Qian
April 16, 2021
Open Access

The Pattern of Microorganisms and Drug Susceptibility in Pediatric Oncologic Patients with Febrile Neutropenia.

Journal of Pathogens
Thanyathorn JungrungruengPiti Techavichit
April 16, 2021

Incidence and predictive biomarkers of Clostridioides difficile infection in hospitalized patients receiving broad-spectrum antibiotics.

Nature Communications
Cornelis H van WerkhovenANTICIPATE Study Group
April 16, 2021

Clinical and microbiological characteristics of Eggerthella lenta bacteremia at a Japanese tertiary hospital.

Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy
Rie NagaokaHiroki Ohge
April 15, 2021
Open Access

Antimicrobial treatment of Erysipelatoclostridium ramosum invasive infections: a systematic review.

Revista Do Instituto De Medicina Tropical De São Paulo
Milos N MilosavljevicSrdjan M Stefanovic
April 14, 2021


Wiadomości lekarskie : organ Polskiego Towarzystwa Lekarskiego
Aidyn G SalmanovStella Kushnirenko
April 14, 2021
Open Access

Investigation of double-carbapenem efficiency in experimental sepsis of colistin-resistant Klebsiella pneumoniae.

Northern Clinics of Istanbul
Imran KosarMehmet Doganay
April 14, 2021

Pharmacological and clinical profile of cefiderocol, a siderophore cephalosporin against gram-negative pathogens.

Expert Review of Clinical Pharmacology
Anselm Jorda, Markus Zeitlinger
April 14, 2021

Updates on bacterial resistance and empirical antibiotics treatment of complicated acute appendicitis in children.

Journal of Pediatric Surgery
Chun Pong Daniel KwokKin Wai Edwin Chan
April 13, 2021
Open Access

[Cost-effectiveness of ceftazidime/avibactam versus colistin + meropenem for treatment of carbapenemic-resistant enterobacteria infections in Chile].

Revista chilena de infectología : órgano oficial de la Sociedad Chilena de Infectología
Magda Gutiérrez A, Cecil Fandiño
April 13, 2021
Open Access

[Carbapenemases produced by Carbapenem-resistant Pseudomonas aeruginosa isolated from hospitals in Chile].

Revista chilena de infectología : órgano oficial de la Sociedad Chilena de Infectología
Jandira S Tomás da CostaGrupo Colaborativo de Resistencia

Sign up to follow this feed and discover related papers.

Related Feeds

Allergy & Infectious Diseases (ASM)

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Anthelmintics (ASM)

Anthelmintics or antihelminthics are a group of antiparasitic drugs that expel parasitic worms (helminths) and other internal parasites from the body by either stunning or killing them and without causing significant damage to the host. Discover the latest research on anthelmintics here.

Anthrax Vaccines (ASM)

Three different types of anthrax vaccines are available; a live-attenuated, an alum-precipitated cell-free filtrate and a protein recombinant vaccine. The effectiveness between the three is uncertain, but the live-attenuated have shown to reduce the risk of anthrax with low adverse events. Here is the latest research on anthrax vaccines.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antitubercular Agents (ASM)

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Ascariasis (ASM)

Ascariasis is a helminthic infection of global distribution with more than 1.4 billion persons infected throughout the world. Here is the latest research.

Aspergillosis (ASM)

Aspergillosis is the name given to a wide variety of diseases caused by infection by fungi of the genus Aspergillus. Aspergillosis occurs in chronic or acute forms which are clinically very distinct. Most cases of acute aspergillosis occur in patients with severely compromised immune systems. Chronic colonization or infection can cause complications in people with underlying respiratory illnesses. Discover the latest research on aspergillosis here.

© 2021 Meta ULC. All rights reserved